Diastolic mechanical properties of the left ventricle after global ischemia. 1991

K Tabayashi, and P P McKeown, and M Miyamoto, and A E Luedke, and R Thomas, and D G Breazeale, and G A Misbach, and M D Allen, and T D Ivey
Department of Surgery, University of Washington School of Medicine, Seattle.

The purpose of this study was to evaluate left ventricular (LV) diastolic mechanical properties after induced global ischemia using reliable new methods. The diastolic function of nonoxygenated crystalloid solution (CC sO2) was compared with those of oxygenated crystalloid (CC cO2) and oxygenated fluorocarbon cardioplegic (FC cO2) solutions. Postischemic ventricular performance was studied in 3 equal (no. 7) groups of dogs subjected to 120 minutes of global ischemia induced at an average myocardial temperature of 18.5 +/- 1.4 degrees C. LV diastolic function (chamber and myocardial stiffness) and relaxation (the exponential fall in LV pressure) were evaluated by sonomicrometry and Millar micrometers before ischemia and at 45 and 60 minutes after ischemia. LV chamber and myocardial stiffness in the CC sO2 group was significantly (p less than 0.05) elevated after ischemia, while the CC cO2 and FC cO2 groups did not show increases in LV chamber and myocardial stiffness after ischemia. LV relaxation before and after ischemia was not changed in any group. The myocardial water content of the CC sO2 group was significantly higher than that of the CC cO2 and FC cO2 groups (p less than 0.05). We conclude that (1) the postischemic increase in LV chamber stiffness in the CC sO2 group was dependent not only on the increase in intrinsic myocardial stiffness but also due to an increase in myocardial edema, and (2) there was no correlation between the LV relaxation rate and the leftward shift of diastolic compliance curves in the CC sO2 group.

UI MeSH Term Description Entries
D007511 Ischemia A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION. Ischemias
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D002314 Cardioplegic Solutions Solutions which, upon administration, will temporarily arrest cardiac activity. They are used in the performance of heart surgery. Cardioplegic Solution,Solution, Cardioplegic,Solutions, Cardioplegic
D003971 Diastole Post-systolic relaxation of the HEART, especially the HEART VENTRICLES. Diastoles
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D005466 Fluorocarbons Liquid perfluorinated carbon compounds which may or may not contain a hetero atom such as nitrogen, oxygen or sulfur, but do not contain another halogen or hydrogen atom. This concept includes fluorocarbon emulsions, and fluorocarbon blood substitutes. Perfluorinated and related polyfluorinated chemicals are referred to as PFAS and are defined as chemicals with at least two adjacent carbon atoms, where one carbon is fully fluorinated and the other is at least partially fluorinated. Fluorocarbon,Fluorocarbon Emulsion,Fluorocarbon Emulsions,Fluorotelomer Phosphate Esters,N-Alkyl Perfluoroalkyl Sulfonamido Carboxylates,PFAS Per- and Polyfluoroalkyl Substances,PFC Perfluorinated Chemicals,PFECAs Perfluoropolyether Carboxylic Acids,Per- and Polyfluoroalkyl Substances,Perfluoroalkane Sulfonamides,Perfluoroalkyl Carboxylates,Perfluoroalkyl Ether Carboxylates,Perfluoroalkyl Polyether Carboxylates,Perfluorocarbon,Perfluorocarbons,Perfluoropolyether Carboxylic Acids,Polyfluorocarbons,Fluorinated Telomer Alcohols,Fluoro-Telomer Alcohols,Polyfluorinated Telomer Alcohols,Telomer Fluorocarbons,Acids, Perfluoropolyether Carboxylic,Alcohols, Fluorinated Telomer,Alcohols, Fluoro-Telomer,Alcohols, Polyfluorinated Telomer,Carboxylates, Perfluoroalkyl,Carboxylates, Perfluoroalkyl Ether,Carboxylates, Perfluoroalkyl Polyether,Carboxylic Acids, Perfluoropolyether,Chemicals, PFC Perfluorinated,Emulsion, Fluorocarbon,Emulsions, Fluorocarbon,Esters, Fluorotelomer Phosphate,Ether Carboxylates, Perfluoroalkyl,Fluoro Telomer Alcohols,Fluorocarbons, Telomer,N Alkyl Perfluoroalkyl Sulfonamido Carboxylates,PFAS Per and Polyfluoroalkyl Substances,Per and Polyfluoroalkyl Substances,Perfluorinated Chemicals, PFC,Phosphate Esters, Fluorotelomer,Polyether Carboxylates, Perfluoroalkyl,Sulfonamides, Perfluoroalkane,Telomer Alcohols, Fluorinated,Telomer Alcohols, Polyfluorinated
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D006324 Heart Arrest, Induced A procedure to stop the contraction of MYOCARDIUM during HEART SURGERY. It is usually achieved with the use of chemicals (CARDIOPLEGIC SOLUTIONS) or cold temperature (such as chilled perfusate). Cardiac Arrest, Induced,Cardioplegia,Induced Cardiac Arrest,Induced Heart Arrest,Cardioplegias

Related Publications

K Tabayashi, and P P McKeown, and M Miyamoto, and A E Luedke, and R Thomas, and D G Breazeale, and G A Misbach, and M D Allen, and T D Ivey
February 1980, Federation proceedings,
K Tabayashi, and P P McKeown, and M Miyamoto, and A E Luedke, and R Thomas, and D G Breazeale, and G A Misbach, and M D Allen, and T D Ivey
July 1992, The American journal of physiology,
K Tabayashi, and P P McKeown, and M Miyamoto, and A E Luedke, and R Thomas, and D G Breazeale, and G A Misbach, and M D Allen, and T D Ivey
March 1985, Circulation,
K Tabayashi, and P P McKeown, and M Miyamoto, and A E Luedke, and R Thomas, and D G Breazeale, and G A Misbach, and M D Allen, and T D Ivey
March 1976, Annals of internal medicine,
K Tabayashi, and P P McKeown, and M Miyamoto, and A E Luedke, and R Thomas, and D G Breazeale, and G A Misbach, and M D Allen, and T D Ivey
June 1985, Journal of cardiography,
K Tabayashi, and P P McKeown, and M Miyamoto, and A E Luedke, and R Thomas, and D G Breazeale, and G A Misbach, and M D Allen, and T D Ivey
August 1990, Circulation research,
K Tabayashi, and P P McKeown, and M Miyamoto, and A E Luedke, and R Thomas, and D G Breazeale, and G A Misbach, and M D Allen, and T D Ivey
September 1979, Circulation research,
K Tabayashi, and P P McKeown, and M Miyamoto, and A E Luedke, and R Thomas, and D G Breazeale, and G A Misbach, and M D Allen, and T D Ivey
January 1974, Circulation,
K Tabayashi, and P P McKeown, and M Miyamoto, and A E Luedke, and R Thomas, and D G Breazeale, and G A Misbach, and M D Allen, and T D Ivey
July 1988, British heart journal,
K Tabayashi, and P P McKeown, and M Miyamoto, and A E Luedke, and R Thomas, and D G Breazeale, and G A Misbach, and M D Allen, and T D Ivey
August 2013, Journal of applied physiology (Bethesda, Md. : 1985),
Copied contents to your clipboard!